VTYX - Balance Sheet - Ventyx Biosciences, Inc.

Current Liabilities	12.8 M
Accounts Payable	3.13 M
Short-Term Debt	1.05 M
Other Current Liabilities	8.59 M
Non-Current Liabilities	9.74 M
Long-Term Debt	0
Other Non-Current Liabilities	9.74 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	27.3	51.6	64.8	70.8	0.2	0.3
Short Term Investments	190.1	200.6	253.1	187.8	0	0
Receivables	0	0	0	0	0	0
Inventory	0	0	0	0	0	0
Other Current Assets	12.3	12.1	12.7	4.4	1 K	40 K
Total Current Assets	229.6	264.3	330.7	263.0	0.2	0.3
PP&E	10.3	12.3	1.9	0.3	0	0
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	35.6	0	38.7	28.1	0	0
Other Long Term Assets	1.0	1.1	96 K	60 K	0	0
Other Assets	0	0	0	0	0	0
Total Assets	276.6	277.7	371.4	291.5	0.2	0.3
LIABILITIES
Accounts Payable	3.1	5.8	6.4	4.7	1.1	0.4
Short Term Debt	1.1	1.0	0.8	0	0	0
Other Current Liabilities	8.6	15.5	9.1	7.6	0.3	0.3
Total Current Liabilities	12.8	22.3	16.4	12.3	1.4	0.6
Long Term Debt	0	11.5	1.1	0	12.6	3.8
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	0	0	0	0	16.8	0
Total Liabilities	22.5	33.8	17.5	12.3	30.9	4.5
EQUITY
Common Stock	7 K	6 K	6 K	5 K	0	0
Retained Earnings	(554.3)	(419.2)	(226.2)	(117.8)	(32.5)	(4.3)
Other Accumulative Comprehensive Income/Loss	0.2	50 K	(1.1)	58 K	0	0
Total Equity	254.0	243.9	(226.2)	(117.8)	(30.7)	(4.1)
Total Liabilities and Equity	276.6	277.7	(208.7)	(105.5)	0.2	0.3
SHARES OUTSTANDING
Common Shares Outstanding	68.5	58.5	52.5	50.4	50.3	50.3

Free